SAB Biotherapeutics Inc. (SABSW)

AI Score

Unlock

0.02

-0.00 (-6.98%)

At close: Apr 16, 2025, 3:54 PM

0.02

0.00%

After-hours: Apr 16, 2025, 04:00 PM EDT

SAB Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	8.9M	9.17M	17.24M	14.03M	56.57M	2.43M	7.77M	13.06M	15.05M	8.33M	16.62M	22.41M	33.21M	667.87K	10.23M	858.05K	12.61M
Short-Term Investments	11.86M	21.23M	20.08M	30.02M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	1.24M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	116.16M	116.16M	116.15M	n/a
Other Long-Term Assets	482.1K	514.41K	521.72K	554.03K	350.23K	371.19K	434K	434K	467.69K	501.39K	535.08K	n/a	n/a	n/a	-116.16M	n/a	n/a
Receivables	54.95K	97.05K	224.92K	193.23K	n/a	n/a	364.12K	763.12K	5.56M	12.94M	9.61M	11.79M	8.01M	n/a	17.11M	n/a	20.57M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.98M	2.04M	2.03M	n/a	2.34M	702.23K	n/a	n/a	n/a	n/a	n/a	n/a	6.34M	n/a	n/a	n/a	n/a
Total Current Assets	23.79M	32.54M	39.58M	46.95M	58.91M	3.13M	9.01M	15.03M	22.1M	22.18M	27.75M	36.17M	48.42M	770.62K	27.77M	1.12M	34.46M
Property-Plant & Equipment	19.92M	20.75M	21.79M	22.63M	24.68M	24.84M	26M	27.21M	28.34M	29.82M	30.87M	31.3M	30.95M	n/a	26.44M	n/a	22.08M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	20.4M	21.26M	22.31M	24.42M	25.03M	25.21M	26.44M	27.64M	28.81M	30.33M	31.4M	31.3M	30.95M	116.16M	26.44M	116.15M	22.08M
Total Assets	44.2M	53.8M	61.89M	71.37M	83.94M	28.34M	35.44M	42.67M	50.9M	52.51M	59.15M	67.47M	79.37M	116.93M	54.21M	117.27M	56.54M
Account Payables	1.69M	1.3M	1.17M	1.24M	945.93K	1.08M	1.4M	1.44M	3.68M	5.48M	4.94M	4.98M	4.46M	n/a	5.5M	n/a	7.38M
Deferred Revenue	n/a	114.7K	114.7K	377.83K	1.32M	1.63M	2.89M	2.94M	n/a	n/a	n/a	n/a	100K	n/a	100K	n/a	100K
Short-Term Debt	811.84K	n/a	1.21M	835.47K	1.85M	1.2M	784.88K	444.48K	772.66K	1.38M	1.33M	1.33M	186.06K	n/a	24.14K	n/a	538.73K
Other Current Liabilities	5.47M	745.5K	3.24M	6.51M	3.69M	3.78M	4.22M	923.16K	8.1M	6.32M	6.06M	8.85M	8.53M	n/a	587.78K	80K	438.94K
Total Current Liabilities	7.98M	8.82M	7.55M	8.3M	10.81M	9.21M	11.01M	13.67M	14.99M	17.1M	16.14M	18.26M	24.68M	322.38K	10.2M	80K	11.06M
Long-Term Debt	3.86M	n/a	n/a	n/a	n/a	n/a	541.64K	541.64K	541.64K	n/a	n/a	n/a	n/a	n/a	25.01K	n/a	172.04K
Other Long-Term Liabilities	6.39M	4.08M	4.09M	6.31M	11.77M	417.1K	595.86K	238.34K	320.93K	357.52K	1.14M	2.87M	10.72M	9.75M	n/a	7.8M	n/a
Total Long-Term Liabilities	10.25M	8.08M	8.22M	10.24M	15.83M	3.87M	4.72M	4.6M	4.85M	4.78M	5.9M	7.96M	16.14M	9.75M	5.76M	7.8M	6.47M
Total Liabilities	18.23M	16.89M	15.77M	18.55M	26.64M	13.08M	15.73M	18.27M	19.85M	21.88M	22.03M	26.21M	40.82M	10.07M	15.95M	7.88M	17.53M
Total Debt	4.67M	4.52M	5.34M	5.45M	5.91M	4.65M	4.9M	5.46M	5.93M	5.8M	6.09M	6.41M	6.74M	n/a	6.92M	n/a	8.13M
Common Stock	935.00	929.00	929.00	929.00	929.00	5.29K	5.29K	5.09K	5.09K	4.36K	4.36K	4.35K	4.35K	116.15M	3.52K	104.39M	3.52K
Retained Earnings	-124.17M	-112.77M	-102.42M	-95.09M	-90.06M	-67.21M	-62.1M	-55.22M	-47.87M	-40M	-32.92M	-28.14M	-29.13M	-9.29M	-13.52M	2.96M	-11.98M
Comprehensive Income	-135.41K	52.13K	-31.35K	-63.45K	26.42K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	25.97M	36.9M	46.12M	52.82M	57.3M	15.26M	19.72M	24.4M	31.06M	30.62M	37.12M	41.26M	38.55M	106.86M	38.26M	109.39M	39.01M
Total Investments	11.86M	21.23M	20.08M	31.26M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	116.16M	116.16M	116.15M	n/a